Liver Cirrhosis with Refractory Ascites: Managing Ascites That Medical Therapy Cannot Control

Refractory ascites in liver cirrhosis represents a subset of patients where standard medical management is no longer sufficient — either the ascites cannot be mobilised, or its early recurrence cannot be satisfactorily prevented. This specific clinical situation warrants a structured, evidence-based protocol distinct from general ascites management.

Clinical scenario: Liver cirrhosis complicated by refractory ascites — defined as ascites that cannot be mobilised, or the early recurrence of which cannot be satisfactorily prevented by medical therapy.

This is a defined, guideline-recognised scenario requiring specific management beyond first-line pharmacological approaches.

Treatment Approach

For patients in this setting, the protocol involves a specialised interventional approach — available at experienced centres — with close patient monitoring required throughout, given a relevant risk profile that includes renal function. The complete patient selection criteria, procedural details, and monitoring protocol are available in the full regimen.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jhep.2018.03.024

Repeated LVP plus albumin (8 g/L of ascites removed) are recommended as first line treatment for refractory ascites (I;1).

Alfapump® implantation in patients with refractory ascites not amenable to TIPS insertion is suggested in experienced centres. However, close patient monitoring is warranted because of the high risk of adverse events including renal dysfunction and technical difficulties (I;2).

View source ↗